Programme
The Reception | Tuesday 25th May 2021 | 18:00 - 20:00
The Danish Embassy, The Ambassador's Residence, 2 Hans Street, London, SW1X ONJ
____________________________________________________________________
The Conference | Wednesday 26th May 2021 | 08:15 - 18:30
8:15 Registration opens, full continental breakfast is served
9:00 Welcome
Mattias Johansson, Director, Ezenze Ltd, Anglonordic Conference Founder
Morning session Chaired by Mary Clark, Managing Director, Optimum Strategic Communications
9:05 Keynote
9:30 What’s hot and what's simmering? - Investment Panel Discussion
10:30 Coffee
11:00 Company Presentations
Biotech Investment Room and Technology Room
Presentations include VAXIMM, a privately held Swiss/German biotech company that is developing oral T-cell immunotherapies
Apply to pitch here.
____________________________________________________________________
12:30 - 13:30 Networking Lunch
____________________________________________________________________
Afternoon session
13:30 DDR Therapeutics - Panel discussion
14:30 Company Presentations
Biotech Investment Room and Technology Room
Presentations: to be announced soon! Apply to pitch here.
15:45 Coffee
16:00 Building your Board - Structure, Diversity, Success - Panel Discussion
16:45 If I knew then what I know today - Panel Discussion
17.45 Conclusions
17.55 - 18:45 Drinks Reception
Hosted by Mattias Johansson, Director, Ezenze Ltd
____________________________________________________________________
1:1 meetings take place throughout the day and are pre-booked online.
Login to add your profile, bookmark prospects and book meetings.
____________________________________________________________________
Attendees
Investors registered so far: Advent Life Science, Albion Technology & General VCT, Alpha Blue Ocean, Alpha Bronze Life Sciences Opportunities Fund, Apollo Ventures, Aratus Capital, Arvic AG, Axon Capital Partners, Bioscience Managers, Biotechnology Business Institute, Bond Asian Ventures, Cascara Ventures Bvba, Catapult Ventures, DeBere Capital Partners, Eli Lilly, ESM Biotech, Esperante, GL Capital, Helsinn Investment Fund, Hermes Partners Intl, Ignite Capital Partners, Inkef Capital, Innovate UK, IP Group, IPF Partners, Kreos Capital, Kurma Partners, Lundbeckfonden Emerge, Lundbeckfonden Ventures, Luminous Ventures, M Ventures, Mercia Asset Management, NeoMed, Newables, Norgine Ventures, o2h Ventures, Optum Ventures, oxford technology 3, Panakes Partners, Pontifax, Questra, Rosetta Capital, Seroba Life Sciences, Seventure Partners, Swelife International, Syncona, Syndicate Room, Trilantic Europe, UCB Ventures, UK Innovation & Science Seed Fund, Xeraya Capital and XOventure.
